PHS
BLU

PFM Health Sciences’s BELLUS Health Inc. BLU Stock Holding History

PFM Health Sciences’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-439,813
Closed -$3.17M – 96
2023
Q1 		$3.17M Buy
439,813
+375,949
+589% +$2.92M 0.14% 68
2022
Q4 		$525K Buy
+63,864
New +$595K 0.02% 84

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

PFM Health Sciences's BLU Position: Q2 2023 in Review

PFM Health Sciences sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 439,813 shares — an estimated $3.17M sold.

PFM Health Sciences first reported a position in BLU in Q4 2022 and held it in 2 quarters. The position peaked at $3.17M in Q1 2023. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • PFM Health Sciences reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • PFM Health Sciences sold 439,813 BELLUS Health Inc. shares in Q2 2023, an estimated $3.17M.
  • PFM Health Sciences first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 2 quarters.
  • PFM Health Sciences's BELLUS Health Inc. position peaked at $3.17M in Q1 2023.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on PFM Health Sciences's 13F filing for Q2 2023, filed 14 Aug 2023.